Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial.
Antibiotic therapy during pregnancy may be beneficial and impacts positively on the reduction of adverse pregnancy outcomes. No studies have been done so far on the effects of daily Co-trimoxazole (CTX) prophylaxis on birth outcomes. A phase 3b randomized trial was conducted to establish that daily...
Main Authors: | Christine Manyando, Eric M Njunju, David Mwakazanga, Gershom Chongwe, Rhoda Mkandawire, Davies Champo, Modest Mulenga, Maaike De Crop, Yves Claeys, Raffaella M Ravinetto, Chantal van Overmeir, Umberto D' Alessandro, Jean-Pierre Van Geertruyden |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4022666?pdf=render |
Similar Items
-
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.
by: Christine Manyando, et al.
Published: (2013-01-01) -
Safety and efficacy of intermittent presumptive treatment with sulfadoxine-pyrimethamine using rapid diagnostic test screening and treatment with dihydroartemisinin-piperaquine at the first antenatal care visit (IPTp-SP+): study protocol for a randomized controlled trial
by: Jean-Bertin Bukasa Kabuya, et al.
Published: (2021-11-01) -
A cross-sectional study of the factors associated with male circumcision status among college youth in Ndola, Zambia, 2016
by: Ernest Kateule, et al.
Published: (2019-06-01) -
Safety and efficacy of lumefantrine-artemether (Coartem<sup>®</sup>) for the treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in Zambian adults
by: Mulenga Modest, et al.
Published: (2006-08-01) -
Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria
by: Michael Nambozi, et al.
Published: (2017-05-01)